Cytokine production, serum levels and disease activity in systemic lupus erythematosus
about
Rationale for interleukin-6 blockade in systemic lupus erythematosusPathogenesis of systemic lupus erythematosusCytokines and MicroRNAs as Candidate Biomarkers for Systemic Lupus ErythematosusLinking susceptibility genes and pathogenesis mechanisms using mouse models of systemic lupus erythematosusInflammatory cytokines in systemic lupus erythematosusEpstein-Barr virus in systemic lupus erythematosus, rheumatoid arthritis and multiple sclerosis—association and causationFollicular Helper T Cells in Systemic Lupus Erythematosus: Why Should They Be Considered as Interesting Therapeutic Targets?Contribution of dendritic cells to the autoimmune pathology of systemic lupus erythematosusXRCC1 Arg399Gln gene polymorphism and the risk of systemic lupus erythematosus in the Polish populationMonocyte chemoattractant protein-1 -2518 A/G single nucleotide polymorphism might be associated with renal disease and thrombocytopenia of SLETocilizumab in systemic lupus erythematosus: data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study.Customized molecular phenotyping by quantitative gene expression and pattern recognition analysisGenetic regulation of serum cytokines in systemic lupus erythematosusEfficacy and cytokine modulating effects of tacrolimus in systemic lupus erythematosus: a review.Upregulated expression level of the growth factor, progranulin, is associated with the development of primary Sjögren's syndromeClinical associations of serum interleukin-17 in systemic lupus erythematosus.Anti-dsDNA antibodies bind to mesangial annexin II in lupus nephritis.Active systemic lupus erythematosus is associated with a reduced cytokine production by B cells in response to TLR9 stimulation.Reduction of forkhead box P3 levels in CD4+CD25high T cells in patients with new-onset systemic lupus erythematosus.Effect of proinflammatory cytokines (IL-6, TNF-α, and IL-1β) on clinical manifestations in Indian SLE patients.Double positive CD4+CD8+ T cells: key suppressive role in the production of autoantibodies in systemic lupus erythematosusInfluence of Atg5 mutation in SLE depends on functional IL-10 genotypeIL-17 and IL-23 in lupus nephritis - association to histopathology and response to treatment.TRIpartite motif 21 (TRIM21) differentially regulates the stability of interferon regulatory factor 5 (IRF5) isoforms.Deranged bioenergetics and defective redox capacity in T lymphocytes and neutrophils are related to cellular dysfunction and increased oxidative stress in patients with active systemic lupus erythematosus.Immune complexes from SLE sera induce IL10 production from normal peripheral blood mononuclear cells by an FcgammaRII dependent mechanism: implications for a possible vicious cycle maintaining B cell hyperactivity in SLE.Differential effect of IL10 and TNF{alpha} genotypes on determining susceptibility to discoid and systemic lupus erythematosus.Raised levels of interleukin 6 in systemic lupus erythematosus correlate with anaemiaCytokine disturbances in systemic lupus erythematosus.Cytokine and chemokine profiles in fibromyalgia, rheumatoid arthritis and systemic lupus erythematosus: a potentially useful tool in differential diagnosis.High Affinity Antibodies against Influenza Characterize the Plasmablast Response in SLE Patients After Vaccination.Interleukin-10 paradox: A potent immunoregulatory cytokine that has been difficult to harness for immunotherapy.Tocilizumab for the treatment of rheumatoid arthritis and other systemic autoimmune diseases: current perspectives and future directions.Roles of pro- and anti-inflammatory cytokines in the pathogenesis of SLEInterleukin 6 Accelerates Mortality by Promoting the Progression of the Systemic Lupus Erythematosus-Like Disease of BXSB.Yaa MiceRNA-seq Analysis Reveals Unique Transcriptome Signatures in Systemic Lupus Erythematosus Patients with Distinct Autoantibody SpecificitiesApparent Hypothalamic-Pituitary-Adrenal Axis Suppression via Reduction of Interleukin-6 by Glucocorticoid Therapy in Systemic Autoimmune DiseasesMS2 VLP-based delivery of microRNA-146a inhibits autoantibody production in lupus-prone mice.Vitamin D receptor gene BsmI, FokI, ApaI and TaqI polymorphisms and the risk of systemic lupus erythematosus.Cytokines in systemic lupus erythematosus
P2860
Q24564990-48F46AF5-FA00-4FDE-9920-277158CB243CQ24672873-1E4F11C4-77BC-4108-9A8B-6F18577BD856Q26782454-6793CE79-263D-4332-B9E7-9CD845418DDCQ26822662-1C8E94EC-2BE1-446E-8143-98B771244F81Q26823647-62FBBA71-9A9A-44BD-9B7F-BF1B22C49CFFQ26830464-F28B5B9B-7D50-433D-A584-B6F2518CCD62Q28067781-A2BEC161-F534-4399-A8B9-3D0EF4E876D1Q28080920-C6D006F5-1EEE-4946-88F3-99FD5B496F9DQ28395086-04EE8A84-358A-43DD-912A-40A9363507C4Q33389262-3D505AF8-6564-4520-A75C-1366FC282261Q33527462-BC6E55CA-0B1C-4C00-ABB8-1016AB8AF9A5Q33681038-6D50D3E7-2EF3-4B8C-8BFC-B8278AD121C0Q33682879-097D6F3A-3764-4F15-B125-B79D049EFD0BQ33960223-BF10C2EE-EC01-4C82-AD4F-02181E4060C9Q34292351-959740ED-7F68-4D83-818E-D64A2E40AF82Q34365880-3E278041-4676-43D1-9CB1-3324A2F6CEEEQ34457056-73ADACD0-296E-410A-AA02-6F14E92FA71FQ34587471-C2E97985-0BDB-41B2-A81B-8EC7BACA704DQ34592421-45015A8B-3C98-4118-B98D-B14CFF8D7C48Q34754611-FB4941E2-BEC2-46C5-AE8A-67120244667EQ34775452-BDB8E613-5524-4D88-BBC0-0E7C88AED492Q35036685-EE9AD355-E9DB-4C27-B351-9045AEE3F6D6Q35078183-AA13C845-1F13-43A8-90D4-C9CF61965DB2Q35217245-61FC920F-C0D0-4B56-A0AB-AAA0DB5A632CQ35326330-F0D32444-49BA-4FE6-8875-01FC63234987Q35552018-853A4E0D-96ED-4D47-84A5-4CEA2FD4A3FBQ35554902-A4EB1203-7E68-413F-BD5A-E0970D1A5F11Q35555688-A7F3CE91-8F7E-4FF0-AD38-274EA07D9764Q35617573-FB65C007-2E92-4326-A762-61BA42F62691Q35619740-0543226F-F696-484C-9D8A-9BAE8B6CA9CDQ35624357-C2F82F81-A745-4699-8747-7E854578660AQ35680472-74340927-28EB-43B7-B89B-B3C3A0D39DC1Q35724900-402434D7-8DFB-4375-89CC-81D45BFDA9EDQ35829864-29BE437A-6085-4D17-928C-6A47E1DB51FDQ35981296-DEC61683-6C5F-4D7E-85A6-D3B348D37E6FQ36190001-ACDD3921-9736-4936-BE81-54157F30D741Q36216180-48CBF480-E51A-4FB8-ABCA-6F8D640DA999Q36456019-19DF4DB2-24D2-44E3-A812-D968206D4B03Q36511431-6C526CA1-7EA4-401D-819A-CB197C24AE20Q36659210-CA85FAD9-4111-48C6-BBAD-B99BD7694051
P2860
Cytokine production, serum levels and disease activity in systemic lupus erythematosus
description
article
@en
wetenschappelijk artikel
@nl
name
Cytokine production, serum levels and disease activity in systemic lupus erythematosus
@en
Cytokine production, serum levels and disease activity in systemic lupus erythematosus
@nl
type
label
Cytokine production, serum levels and disease activity in systemic lupus erythematosus
@en
Cytokine production, serum levels and disease activity in systemic lupus erythematosus
@nl
prefLabel
Cytokine production, serum levels and disease activity in systemic lupus erythematosus
@en
Cytokine production, serum levels and disease activity in systemic lupus erythematosus
@nl
P2093
P1476
Cytokine production, serum levels and disease activity in systemic lupus erythematosus
@en
P2093
I Gunnarsson
J Rönnelid
P304
P407
P577
2000-09-01T00:00:00Z